Pove was generally safe and well tolerated with adverse events (AEs) that were mostly mild or moderate in severity. There were no serious adverse events related to povetacicept. The safety data is ...

H OUSTON -- A novel self-administered shot that inhibits two key immunoregulatory cytokines reduced proteinuria in patients ...

The benefits are observed across patient subtypes and potentially offer the chance to avoid dialysis and implement a new standard of care.

The VISIONARY trial is testing sibeprenlimab, a humanized IgG2 monoclonal antibody, in patients with IgA nephropathy, a population at high risk for kidney failure.

Telitacicept is a dual inhibitor of both B-lymphocyte stimulator and a proliferation-inducing ligand, cytokines that promote B cell survival and production of pathogenic galactose-deficient IgA1.

3D printing technology enables precise drug design, personalized dosing, and versatile release modes, benefiting patient-centric treatments. At AAPS PharmSci 360, Xialing Li, PhD, says 3D-printed ...

USA: A novel self-administered drug, Atacicept, which inhibits two key immunoregulatory cytokines, showed a 45.7% reduction in proteinuria among patients with IgA nephropathy in the phase III ORIGIN 3 ...

Biohaven Ltd. narrows focus to three late-stage clinical programs and implements cost-cutting to address heavy R&D spending.

IgA nephropathy, also known as Berger’s disease, is a progressive, autoimmune, chronic kidney disease that predominantly affects adults between the ages of 20 and 40. It is characterized by the ...

May 11—(StatePoint) IgA nephropathy is a progressive, autoimmune, chronic disease that predominantly affects adults between the ages of 20 and 40, with an annual global incidence of 2.5 cases per ...

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

IgA nephropathy is hard to predict. But there’s one thing experts know. People with strong emotional and social support systems tend do better in the long run. And it’s best to live your life to the ...